We also make strong reference to the post hoc analysis in the Intergroup 0139 trial showing a highly significant improvement in survival for patients undergoing lobectomy in the CRS arm matched to patients suitable for lobectomy undergoing CR.
← all excerpts
What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling.
1
—
—